A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat

PHASE3CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

December 31, 2003

Conditions
Pharyngitis
Interventions
DRUG

valdecoxib

valdecoxib 20 mg tablet by mouth twice daily (BID) for 2 doses over a 24-hour period

DRUG

valdecoxib

valdecoxib 40 mg tablet by mouth once daily (QD) for 2 doses over a 24-hour period

DRUG

placebo

placebo tablet by mouth for 2 doses over a 24-hour period

Trial Locations (2)

33433

Pfizer Investigational Site, Boca Raton

06269-2011

Pfizer Investigational Site, Storrs

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00647829 - A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat | Biotech Hunter | Biotech Hunter